About this trial
Pain management following thyroidectomies, which can cause mild to moderate postoperative pain, particularly in the first 24 hours following surgery, has received little attention . The incision of the wound, neck hyperextension, retraction of the wound margins during surgery, and dissection are the main reasons of post-thyroidectomy discomfort . After thyroid surgery, pain management improves patients' quality of life and facilitates a speedy return to regular daily activities.
the aim of the study to evaluate the effects of bupivacaine instillation after thyroidectomy against infiltration into the surgical field in order to reduce postoperative discomfort following thyroid surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Normal thyroid function patients of both genders scheduled for thyroid surgery will included in this study
If they are over the age of 18
If they had an ASA score (American Society of Anesthesiology) I, II.
A Score of Mallampati I , II.
Disqualifiers
Patient refused to participate in the study.
Patients will be excluded if they have any analgesic medication or corticosteroid drug prior surgery or
A known or suspected allergy to local anesthetics,
if the duration of surgery is greater than 5 h and if a major complication of surgery or anesthesia (major bleeding, allergy to anesthetic products).
Trial design
Parallel
Treatments tested in this trial
Bupivacaine
Drugthe patients will receive the content of a syringe (10 ml of bupivacaine 0.25%)
Adrenaline
Drugthe patients will receive the content of a syringe 15 μg adrenaline
Lidocaine (drug)
Drugthe patients will receive the content of a syringe 70 ml Lidocaine .
Treatment groups
Trial outcomes
Primary outcomes
Total analgesic consumption
Total analgesic consumption at 1st. 24 hours postoperative
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: